Crow Point Partners’s Amgen AMGN Stock Holding History

Crow Point Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-300	Closed	-$51K	–	128
2018 Q1	$51K	Buy	+300	New	+$55.1K	0.01%	199
2017 Q3	–	Sell	-388	Closed	-$67K	–	234
2017 Q2	$67K	Hold	388	–	–	0.01%	178
2017 Q1	$64K	Buy	388 +91	+31%	+$15.1K	0.01%	223
2016 Q4	$43K	Sell	297 -1,045	-78%	-$157K	0.01%	214
2016 Q3	$222K	Buy	+1,342	New	+$227K	0.03%	150
2015 Q3	$491K	Sell	3,547 -125	-3%	-$19.7K	0.07%	107
2015 Q2	$564K	Buy	3,672 +225	+7%	+$36K	0.08%	107
2015 Q1	$551K	Buy	+3,447	New	+$543K	0.08%	104

Other funds holding AMGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Crow Point Partners's AMGN Position: Q2 2018 in Review

Crow Point Partners sold out of Amgen (AMGN) in Q2 2018, closing a stake of 300 shares — an estimated $51K sold.

Crow Point Partners first reported a position in AMGN in Q1 2015 and held it in 8 quarters. The position peaked at $564K in Q2 2015. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

Crow Point Partners reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
Crow Point Partners sold 300 Amgen shares in Q2 2018, an estimated $51K.
Crow Point Partners first reported a position in Amgen in Q1 2015 and held it in 8 quarters.
Crow Point Partners's Amgen position peaked at $564K in Q2 2015.
1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Crow Point Partners's 13F filing for Q2 2018, filed 14 Aug 2018.